Edition: Australia  
One News Page
“Probably the fastest-access news portal in the world”
> >

Clovis Oncology's cancer drug Rubraca succeeds in key study

Reuters Monday, 19 June 2017 ()
(Reuters) - Clovis Oncology Inc said its ovarian cancer drug Rubraca slowed disease progression in a late-stage trial involving patients with various gene mutations who had undergone initial therapy.
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

You Might Like


Other recent news in Health

22 million Americans would become uninsured under Senate health-care bill, CBO estimatesCANADA nurse Elizabeth Wettlaufer jailed for life for murders
MEDICAID rollback may up the risk of advanced stage breast cancer diagnosesCBO projects SENATE HEALTH BILL would drive up number of uninsured
Linde's Lincare settles U.S. whistleblower case for $20 MILLIONStudy: HEALTH INSURANCE saves lives
Few players screened for concussions in last soccer WORLD CUPCHARLIE GARD parents lose European court appeal
New form of Roche's Esbriet approved in EUROPE for lung disorderDrinking water in NORTH CAROLINA being tested for toxic substance

Twitter

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+